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Purpose: To determine the prevalence of polycystic ovary syndrome 
(PCOS) in women who exercise regularly.  
Methods: All women under age 45 from an industrial company who 
had past history of exercising more than 6 months enrolled in this 
cross-sectional study. Prevalence of PCOS and comparison of BMI 
between PCOS and non-PCOS subgroups was done. The diagnosis 
of PCOS was based on the revised 2003 Rotterdam ESHRE/ASRM 
consensus criteria and exclusion of related disorders. 
Results: The prevalence of PCOS in was 8.8%; 95% CI: 8.5%-
9.1%. In obese subjects, mean BMI differed significantly between 
PCOS and non-PCOS women (29.3 ±3.3 kg/m² vs. 27.8 ± 2 kg/m², 
P=0.03). In lean subjects, there was no statistically significant 
difference in terms of BMI between PCOS and non-PCOS women 
(21.4 ± 1.9 kg/m² vs. 21.2 ± 2 kg/m², P>0.05). 
Conclusion: Obese PCOS patients show more difficulty in losing 
weight by exercise than lean PCOS patients.  The role of hormonal 
alterations and PCOS per se in the responsiveness of weight loss to 
exercise remains to be determined. 
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INTRODUCTION 
olycystic ovary syndrome (PCOS) is a complex 
heterogeneous endocrine disorder. It is a common 
disorder affecting 4-12% of women of reproductive 
age
[1,2]. PCOS was first described in the United States 
in 1935
[3]. PCOS is characterized by chronic 
anovulation and hyperandrogenism in the absence of 
underlying adrenal or pituitary disease. Women with 
PCOS may complain about variable clinical 
manifestations including oligomenorrhea, hirsutism, 
acne, and infertility 
[4]. Approximately 75% of these 
women suffer from infertility due to anovulation. 
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Therefore, it is the most common cause of anovulatory 
infertility 
[5,6]. PCOS is also reported to be associated 
with obesity, insulin resistance and type ΙΙ diabetes, 
dyslipidemia, hypertension, cardiovascular disease and 
endometrial carcinoma 
[7,8,9]. Approximately 50-60% of 
women with the syndrome are overweight or obese 
compared to 30% of women in the general 
population
[10,11]. 
     Treatment of PCOS must focus both on normalizing 
short-term signs of hyperandrogenism and anovulation 
and on reducing metabolic complications. This can be 
achieved through pharmacological intervention or 
preferably lifestyle modification
[12]. The most preferred 
and effective method of treatment of PCOS is lifestyle 
modification. Weight loss is an important treatment 
strategy.   
     Weight loss improves practically every parameter of 
PCOS. In obese, anovulatory PCOS women, weight 
loss restores ovulation and pregnancy rates, decreases 
insulin levels, diminishes acanthosis nigricans, lowers 
testosterone levels while raising sex hormone binding 
globulin (SHBG) levels, and improves psychological 
considerations 
[13,14].  
     To our knowledge, there is no study to evaluate the 
prevalence of PCOS in women who regularly exercise. 
Our main objective was to estimate the frequency of 
PCOS in physically active women and to determine the 
effect of exercise on body mass index (BMI) in this 
group. 
METHODS AND SUBJECTS 
This cross-sectional study was carried out from January 
2005 to January 2006 at Tehran University of Medical 
Sciences, Tehran, Islamic Republic of Iran. The 
participants were female employees of a company who 
had regular physical activities.  
     Inclusion criteria were consisted of being less than 
45 years of age and having past history of exercising 
more than six months. Exclusion criterion was the 
presence of any serious medical condition. The study 
group consisted of 294 women aged between 20 and 45 
years who had regular physical activities. 
     Subjects  completed  an  interviewer-administered 
questionnaire. The questionnaire contained questions 
on demographic data, medication usage, and personal 
medical history. Demographic data collected included 
age, education, menarche, type of exercise, duration of 
physical activity (expressed in hours per week), and 
length of physical activity (expressed in months). 
During the visit, participants’ heights and weights were 
measured, and BMI (in kg/m²) was calculated as 
weight (in kg) divided by height (in m) squared.  
     We used past medical history and laboratory data 
for cases with previous diagnosis of PCOS. A complete 
workup for screening of PCOS was performed in other 
participants. Accordingly, prevalence of PCOS was 
calculated. 
Diagnosis of PCOS:  The diagnosis of PCOS was 
made according to the revised 2003 Rotterdam 
ESHRE/ ASRM consensus criteria and exclusion of 
related disorders 
[15]. Data collected from past medical 
history of participants with previously established 
diagnosis of PCOS and current screening of other 
participants was the basis of making the diagnosis of 
PCOS. Oligoamenorrhea was defined as eight or less 
menses per year. Sonographic diagnosis of PCO was 
confirmed upon the condition of having 12 or more 
follicular cysts, 2-9 mm in diameter and/or increased 
ovarian volume (>10 ml³) 
[16]. Clinical evidence of 
hyperandrogenism was a Ferriman–Gallwey score ≥ 8, 
indicating hirsutism and/or presence of moderate to 
severe acne
[17]. Severe acne was characterized by 
presence of inflammatory nodules, in addition to 
comedones, papules, and pustules. Hyperandrogenemia 
was defined as an androgen level above normal values 
[a total testosterone ≥ 2.94 nmol/liter (88 ng/dl) or 
dehydroepi- androsterone sulfate (DHEAS) ≥ 6.64 
mol/liter (2750 ng/ml)] to screen participants with one 
of the two criteria of oligomenorrhea or polycystic 




        Other medical illnesses such as hypothyroidism, 
hyperprolactinaemia, congenital adrenal hyperplasia, 
Cushing’s syndrome, androgen-secreting  tumors,      




Statistical analysis:  The statistical analysis was 
performed using the Statistical Package for Social  
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Sciences, version 10.0 (SPSS Inc., Chicago, IL). Data 
were expressed as mean ±SD (for parametric variables) 
and median, 10
th, and 90
th percentile (for nonparametric 
variables), and percentile of total as appropriate. The 
primary outcome measure was the prevalence of PCOS 
in physically active women. We analyzed BMI in 
PCOS and non-PCOS subjects to determine the 
influence of exercise on BMI. The tests used were 
unpaired t-test, Mann-Whitney U test, and chi-square 
test.  P<0.05 was considered statistically significant. 
Ethical approval was obtained from Ethics Committee 
of Tehran University of Medical Sciences. Written 
consent was obtained from each participant. 
RESULTS 
A total number of 294 women were entered into the 
study. Demographic characteristics of the studied 
women are presented in Table 1.   
      Age range of the subjects was from 20 to 45 years 
with a mean (±SD) of 33.3 (± 5.6) years. Menarche 
ranged from 9 to 17 years old with a mean (±SD) of 
12.7 (± 1.4) years. Among 44 patients with oligo-
amenorrhea or amenorrhea, one suffered from 
hypothalamic amenorrhea. The range of BMI was 16.8-
34.9 kg/m². The score of hirsutism ranged from 0 to 18. 
A total of 87 (29.6%) participants had hirsutism score 
≥ eight. 16% of the participants had moderate to severe 
degrees of acne. One or both polycystic ovaries in 
ultrasound investigation were found in 48 subjects. 
Among this group, 21 (43.8%) patients were 
categorized as having PCOS.  
     The range of exercise time was 1 to 7 hours/week 
with a mean (±SD) of 3.0 (± 1.5) hours. The 
participants had a past history of exercising from 6 to 
60 months with a mean (±SD) of 15.4 (± 11.0) months. 
Type of exercise was regular walking in 47.9% and 
other types of exercise such as swimming or aerobics 
in 52.1% of the participants.  
     PCOS was confirmed in 26 (8.8%; 95% CI: 8.5%- 
9.1%) participants. Confirmation of PCOS was based 
on oligoamenorrhea and polycystic ovaries in four 
patients. In 14 patients, confirmation of PCOS was 
based on existence of oligoamenorrhea, clinical and/or 
biochemical hyperandrogenism and polycystic ovaries. 
Three patients with a diagnosis of PCOS had regular 
menses and diagnosis of PCOS was based on clinical 
and/or biochemical hyperandrogenism and polycystic 
ovaries.  In 5 patients, the ovaries were in the normal 
range in ultrasound investigation, however they fell 
into the category of PCOS due to the presence of 
oligoamenorrhea and clinical and/or biochemical 
hyperandrogenism. As hirsutism was defined as 
Ferriman–Gallwey score ≥ eight, 57.7% (15/26) of 
PCOS patients were hirsute whereas hirsutism was 
found in 26.9% (72/268) of non-PCOS patients (P = 
0.001). The prevalence of moderate or severe acne was 
higher in PCOS group (30.8%) than non-PCOS group 
(14.6%) (P=0.03).  
     Our study population included two groups, PCOS 
(26 cases) and non-PCOS (268 cases). The differences 
Table1: Demographic characteristics of subjects (PCOS and non-PCOS groups) 
Characteristic  Definition  No = 294  Mean (±SD) or % 
Body mass index (kg/m²)      22.8 ± 3.6 
Irregular menses   33/294  14.9% 
Score of hirsutism      6.8 ± 3.3 













Type of exercise 
Regular walking 
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Mean age (y)  31 (22.7-39)  33 (28-42)  0.007* 
Mean menarche (y)  12.7 ± 0.9  12.6 ± 1.4  NS
‡ 
BMI (kg/m²)  23.8 (19-33.4)  22.02 (18.5-27.4)  0.03* 
Current use of oral 
contraceptive pills  7.7%  9.1%  NS
# 
Duration of exercise (hours)  31.5 (8-108)  26 (12-90)  NS* 
Regular walking   49.1%  44.5%  NS
# 
* Mann-Whitney U test; ‡ Unpaired t-test; # Chi-square test 
 NS= Non-significant 
of variables were analyzed between PCOS and non-
PCOS subgroups (Table 2). A total of 42.3% (11/26) 
PCOS patients had BMI over 25 kg/m², while the 
prevalence of high BMI was 20.5% (55/268) in non-
PCOS group (P=0.01).  
     We divided participants into two subgroups based 
on BMI. Among obese subjects (BMI > 25 kg/m²), the 
prevalence of PCOS was 16.6% (11/66). Using 
unpaired t-test, in obese subjects mean BMI differed 
significantly between PCOS and non-PCOS patients 
(29.3 ± 3.3 kg/m² versus 27.8 ± 2 kg/m²; P = 0.03). The 
prevalence of PCOS was 7% (15/213) among lean 
subjects (BMI ≤ 25 kg/m²). In lean subjects there was 
no statistically significant difference in terms of BMI 
between PCOS and non-PCOS patients (21.4 ± 1.9 
kg/m² vs. 21.2 ± 2 kg/m²; P>0.05). 
DISCUSSION 
The main outcome of this study was to estimate the 
frequency of PCOS in a selected group of females. We 
reported the prevalence of PCOS in adult women who 
exercise regularly, using the new Rotterdam 
Consensus.  In our study, PCOS was detected in 8.8% 
of participants. 
     It is emphasized that the most preferred and most 
effective method of treatment for PCOS is lifestyle 
modification 
[20]. Nevertheless, how much lifestyle 
modifications are practical in PCOS patients?  
Randeva et al showed that exercise, such as regular 
walking, reduces waist-to-hip ratio, an indicator of 
diabetes and other morbidities, and homocysteine 
levels, an indicator of cardiovascular risk, in 
overweight PCOS women. However only half (12/21) 
of their subjects completed the exercise program
[21].  
    In  a  study,  researches offered 33 obese PCOS 
patients a 1200 kcal/day diet. Patients were simply 
advised to do some swimming or aerobics at least once 
or twice a week though no information was reported as 
to the actual duration and/or intensity achieved. They 
emphasized that not directly ascertain if the prescribed 
diet was followed.  A total of 24% of their patients 
failed to lose weight. Only 33% achieved 10% decrease 
of body weight 
[22]. It seems that losing weight by 
lifestyle modifications is difficult in a special subgroup 
of PCOS patients. 
Although weight loss improves practically every 
parameter of PCOS, Wright et al. concluded that 
differences in dietary intake and physical activity alone 
are not sufficient to explain differences in weight 
between women with and without PCOS 
[23]. Our study 
confirms the findings by Wright et al. about lifestyle. 
We showed that although the mean time of exercise did 
not differ significantly between PCOS and non-PCOS 
subgroups, frequency of obesity in women with PCOS 
was higher than non-PCOS subgroup of the same 
sample. This difference could be contributed to  
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interaction between metabolic disturbances and 
lifestyles such as dietary intake and exercise.  
Previous researchers have speculated that women 
with PCOS are obese due to a tendency toward 
overeating, particularly sweet or starchy foods 
[24]. 
Faloria et al. evaluated the effect, if any, of obesity on 
metabolic features, body composition and fat 
distribution of patients with PCOS 
[25]. They showed 
that none of the lean subjects suffered from metabolic 
syndrome as opposed to 37% of overweight-obese 
patients and 33.3% of overweight-obese control 
subjects. It seems that metabolic mechanisms act 
differently between lean and obese subgroups. 
Therefore we divided our sample to lean and obese 
subgroups. 
        We showed that mean BMI difference between 
PCOS and non-PCOS obese subjects was statistically 
significant, although the difference was not statistically 
significant between lean PCOS and non-PCOS 
subjects. It seems that obese PCOS patients had some 
negative factors which acted against long term 
maintenance of weight loss. Wright et al. results 
confirm our findings.  After dividing the study 
population to lean and obese subgroups, they 
concluded that energy intake of normal-weight women 
with PCOS was significantly lower than that of 
normal-weight women without PCOS. Conversely, the 
energy intake of obese women with PCOS was greater 
than that of obese women without the syndrome, 
although the difference was not statistically significant. 
They emphasized that women with PCOS should 
restrict significantly energy intake in order to maintain 
a normal weight
 [23]. In the same way, the effect of 
exercise in long term could be less efficient in obese 
patients.  
     Long-term maintenance of weight loss among obese 
population
 is less likely 
[26]. This issue is exaggerated in 
obese PCOS subjects due to impressive correlation 
between metabolic characteristics, lifestyle such as 
physical activity and dietary intake, and obesity.     
   Although lifestyle modifying measures, such as diet 
control and exercise, could play an important role in 
treatment of PCOS, adding more special programs to 
overcome non-compliance and to lower dropout rates 
of trials for weight loss is necessary
[27]. Further 
research is necessary to determine the relative 
contributions of lifestyle including exercise and dietary 
intake, and PCOS. Designing cohort studies to 
determine which factors influence weight loss and/or 
long term maintenance of weight loss in PCOS patients 
will clarify the degree of exercise effectiveness. 
CONCLUSION 
In this study, mean BMI differed significantly between 
PCOS and non-PCOS women. Obese PCOS patients 
show more difficulty in losing weight by exercise than 
lean PCOS patients.  The role of hormonal alterations 
and PCOS per se in the responsiveness of weight loss 
to exercise remains to be determined. 
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